Roger Jeffs
Known title: Chief Executive OfficerCIK: 0001231615
Roger Jeffs's purchase track record
How the stock did after each of Roger Jeffs's open-market purchases, measured from the purchase date. Several fills within a week count as one purchase.
Purchases measured
4
of 4 since November 19, 2021
Stock higher 6 months later
75%
3 months: 50%
Median 6-month return
+35.6%
3 months: +48.6%
Beat the S&P 500
100%
median +34.9% vs. index
| Purchase | Stock | Amount | 3 months | 6 months | S&P 500, 6 mo. |
|---|---|---|---|---|---|
| 12/14/2023 | LQDA | $1.00M | +110.1% | +84.2% | +15.1% |
| 8/31/2022 | LQDA | $249K | -13.0% | +28.8% | -0.1% |
| 5/24/2022 | LQDA | $99K | +116.6% | +42.4% | +1.6% |
| 11/19/2021 | AXSM | $147K | -17.4% | -11.6% | -17.0% |
Computed by MarketWall from SEC Form 4 filings and daily closing prices (close on the purchase date to the close about 3 and 6 months later). Companies that have since delisted are not included. Past results, not investment advice.
Associated companies
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 5, 2026
Deutsche Bank cuts Axsome Therapeutics price target to $267. Deutsche Bank maintained its positive stance on Axsome Therapeutics but lowered its price target to $267. This adjustment comes as the stock trades near a key support level, with recent technical signals indicating a rejection at that price point. While other analysts continue to highlight the company's potential, the latest target remains below the current average analyst estimate.
Transaction History
| LQDA | ▼ Sell | Open Market | 32,744 | $2.3M | 7/13/2026 | View on chart |
| LQDA | ▼ Sell | Open Market | 2,505 | $179K | 7/13/2026 | View on chart |
| LQDA | ▲ Buy | Option Exercise | 13,834 | — | 7/10/2026 | View on chart |
| LQDA | ▲ Buy | Option Exercise | 14,333 | — | 7/10/2026 | View on chart |
| AXSM | ▼ Sell | Open Market | 286 | $71K | 6/11/2026 | View on chart |
| AXSM | ▼ Sell | Open Market | 286 | $70K | 6/10/2026 | View on chart |
| AXSM | ▲ Buy | Option Exercise | 1,429 | — | 6/8/2026 | View on chart |
| LQDA | ▼ Sell | Open Market | 6,428 | $400K | 5/27/2026 | View on chart |
| LQDA | ▼ Sell | Open Market | 25,000 | $1.5M | 5/26/2026 | View on chart |
| LQDA | ▼ Sell | Open Market | 25,000 | $1.5M | 5/22/2026 | View on chart |
| LQDA | ▼ Sell | Open Market | 25,000 | $1.5M | 5/21/2026 | View on chart |
| LQDA | ▼ Sell | Open Market | 25,000 | $1.5M | 5/20/2026 | View on chart |
| LQDA | ▼ Sell | Open Market | 25,000 | $1.5M | 5/19/2026 | View on chart |
| LQDA | ▼ Sell | Open Market | 25,000 | $1.4M | 5/18/2026 | View on chart |
| LQDA | ▼ Sell | Open Market | 25,000 | $1.4M | 5/15/2026 | View on chart |
| LQDA | ▼ Sell | Open Market | 25,000 | $1.5M | 5/14/2026 | View on chart |
| LQDA | ▼ Sell | Open Market | 25,000 | $1.4M | 5/13/2026 | View on chart |
| LQDA | ▼ Sell | Open Market | 25,000 | $1.4M | 5/12/2026 | View on chart |
| LQDA | ▼ Sell | Open Market | 25,000 | $1.0M | 5/11/2026 | View on chart |
| LQDA | ▼ Sell | Open Market | 25,000 | $1.1M | 5/8/2026 | View on chart |
| LQDA | ▼ Sell | Open Market | 25,000 | $1.1M | 5/7/2026 | View on chart |
| LQDA | ▼ Sell | Open Market | 25,000 | $1.0M | 5/6/2026 | View on chart |
| LQDA | ▼ Sell | Open Market | 25,000 | $1.0M | 5/5/2026 | View on chart |
| LQDA | ▼ Sell | Open Market | 18,839 | $765K | 4/17/2026 | View on chart |
| LQDA | ▼ Sell | Open Market | 25,000 | $1.0M | 4/16/2026 | View on chart |
| LQDA | ▼ Sell | Open Market | 25,000 | $1.0M | 4/15/2026 | View on chart |
| LQDA | ▼ Sell | Open Market | 3,300 | $132K | 4/14/2026 | View on chart |
| LQDA | ▼ Sell | Open Market | 32,744 | $1.3M | 4/13/2026 | View on chart |
| LQDA | ▼ Sell | Open Market | 21,433 | $860K | 4/10/2026 | View on chart |
| LQDA | ▲ Buy | Option Exercise | 13,834 | — | 4/10/2026 | View on chart |
| LQDA | ▲ Buy | Option Exercise | 14,333 | — | 4/10/2026 | View on chart |
| LQDA | ▼ Sell | Open Market | 25,000 | $1.0M | 4/9/2026 | View on chart |
| LQDA | ▲ Buy | Grant | 115,344 | $0 | 1/16/2026 | View on chart |
| LQDA | ▼ Sell | Open Market | 66,610 | $2.5M | 1/12/2026 | View on chart |
| LQDA | ▲ Buy | Option Exercise | 57,332 | — | 1/9/2026 | View on chart |
| LQDA | ▲ Buy | Option Exercise | 13,833 | — | 1/9/2026 | View on chart |
| LQDA | ▼ Sell | Open Market | 20,261 | $474K | 10/13/2025 | View on chart |
| LQDA | ▲ Buy | Option Exercise | 13,834 | — | 10/10/2025 | View on chart |
| AXSM | ▼ Sell | Open Market | 13,464 | $1.7M | 9/2/2025 | View on chart |
| AXSM | ▼ Sell | Open Market | 20,000 | $2.4M | 8/29/2025 | View on chart |
| AXSM | ▼ Sell | Open Market | 20,000 | $2.4M | 8/28/2025 | View on chart |
| AXSM | ▼ Sell | Open Market | 20,000 | $2.4M | 8/27/2025 | View on chart |
| AXSM | ▼ Sell | Open Market | 20,000 | $2.4M | 8/26/2025 | View on chart |
| AXSM | ▼ Sell | Open Market | 16,694 | $2.0M | 8/22/2025 | View on chart |
| LQDA | ▼ Sell | Open Market | 20,252 | $289K | 7/14/2025 | View on chart |
| LQDA | ▼ Sell | Open Market | 20,252 | $289K | 7/14/2025 | View on chart |
| LQDA | ▲ Buy | Option Exercise | 13,833 | — | 7/11/2025 | View on chart |
| LQDA | ▲ Buy | Option Exercise | 13,833 | — | 7/11/2025 | View on chart |
| LQDA | ▼ Sell | Open Market | 30,610 | $519K | 6/4/2025 | View on chart |
| LQDA | ▲ Buy | Option Exercise | 69,169 | — | 6/3/2025 | View on chart |
| LQDA | ▼ Sell | Open Market | 14,130 | $192K | 4/14/2025 | View on chart |
| LQDA | ▼ Sell | Open Market | 22,343 | $263K | 1/14/2025 | View on chart |
| LQDA | ▲ Buy | Grant | 229,327 | $0 | 1/11/2025 | View on chart |
| LQDA | ▼ Sell | Open Market | 8,053 | $89K | 10/14/2024 | View on chart |
| LQDA | ▼ Sell | Open Market | 8,053 | $101K | 7/12/2024 | View on chart |
| LQDA | ▼ Sell | Open Market | 8,360 | $122K | 4/12/2024 | View on chart |
| LQDA | ▼ Sell | Open Market | 28,583 | $452K | 3/18/2024 | View on chart |
| AXSM | ▼ Sell | Open Market | 2,347 | $168K | 3/15/2024 | View on chart |
| AXSM | ▲ Buy | Option Exercise | 2,347 | $70K | 3/15/2024 | View on chart |
| AXSM | ▲ Buy | Option Exercise | 13,000 | $286K | 3/14/2024 | View on chart |
| AXSM | ▼ Sell | Open Market | 13,000 | $906K | 3/14/2024 | View on chart |
| AXSM | ▲ Buy | Option Exercise | 16,976 | $433K | 3/14/2024 | View on chart |
| AXSM | ▼ Sell | Open Market | 16,976 | $1.2M | 3/14/2024 | View on chart |
| LQDA | ▲ Buy | Grant | 221,338 | $0 | 1/11/2024 | View on chart |
| LQDA | ▲ Buy | Open Market | 139,665 | $1.0M | 12/14/2023 | View on chart |
| LQDA | ▲ Buy | Grant | 289,500 | $0 | 1/11/2023 | View on chart |
| LQDA | ▲ Buy | Option Exercise | 15,807 | — | 1/3/2023 | View on chart |
| LQDA | ▲ Buy | Option Exercise | 47,423 | — | 10/3/2022 | View on chart |
| LQDA | ▲ Buy | Open Market | 43,820 | $244K | 9/6/2022 | View on chart |
| LQDA | ▲ Buy | Open Market | 993 | $5K | 8/31/2022 | View on chart |
| LQDA | ▲ Buy | Open Market | 28,000 | $99K | 5/24/2022 | View on chart |
| LQDA | ▲ Buy | Grant | 154,167 | $0 | 3/31/2022 | View on chart |
| AXSM | ▲ Buy | Open Market | 3,950 | $147K | 11/19/2021 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 7, 2026
Liquidia shares fall on patent court loss and analyst downgrades
Liquidia stock is down sharply after a court ruling regarding YUTREPIA patent access, which analysts say clouds the drug's future. Wells Fargo downgraded the stock to Equal-Weight and lowered its price target to $30, while other analysts also cut their targets. The stock is currently trading near its 52-week low, reflecting significant market concern over the legal outcome.
Liquidia shares fall on patent court loss and analyst downgrades. Liquidia stock is down sharply after a court ruling regarding YUTREPIA patent access, which analysts say clouds the drug's future. Wells Fargo downgraded the stock to Equal-Weight and lowered its price target to $30, while other analysts also cut their targets. The stock is currently trading near its 52-week low, reflecting significant market concern over the legal outcome.